Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Kidney Int. 2012 Sep 26;83(2):316–322. doi: 10.1038/ki.2012.349

Table 4.

Clinical characteristics for the 20 families affected with INF2-related disease.

Family ID Self-reported Ethnicity/Country Ages at disease onset Number affected Ages at ESRD Number with ESRD Histology Number with Biopsy
FG-BR European ancestry/Canada 12–67 19 32–67 6 FSGS 7
FG-DM European ancestry/Ireland and USA 13–18 2 21–29 2 FSGS 2
FG-EA African American/USA 27–33 3 30–40 2 FSGS 1
FG-EF European ancestry/USA 19–35 5 49 1 FSGS 3
FG-EP European ancestry/USA 11–13 3 13–14 3 FSGS 3
FG-ER European ancestry/Canada 13–60 9 20–50 6 Unclear 3
FG-FG European ancestry/USA 12–72 7 17–60 3 FSGS 3
FG-GY African American/USA 17–30 8 17–30 7 FSGS 2
FG-HT European ancestry/USA 13–29 9 21–22 9 FSGS 4
FG-JN European ancestry/USA 22–45 10 30–45 4 FSGS At least 1
FG-JY European ancestry/Australia 21-? 2 35 1 FSGS 3
FG-KM European ancestry/Poland 15–24 4 25–44 2 FSGS 2
FG-KQ Asian/USA ? 2 26-? 2 FSGS 1
FG-LL European ancestry 19 2 19 1 FSGS At least 1
FG-LP European ancestry/USA 17–27 4 25–28 3 FSGS 1
FG-LW European ancestry 22–30 4 27–30 3 FSGS 1
FG-LY European ancestry/France 18 4 33 3 FSGS 1
FG-ME European ancestry 15–16 3 - 0 FSGS 1
FS-B European ancestry/USA 13–21 5 23–30 4 FSGS 3
FS-V European ancestry/Sweden and Denmark 15 6 30 2 FSGS 1
HHS Vulnerability Disclosure